[A multivalent antineoplastic vaccine comprised of the bcr-abl oncogene breakpoint fusion peptide that elicits a bcr-abl specific T-cell immune response. (NCI04) ( NCI )]
UMLS (NCI) C0879331bcr-abl vaccine
- Amino Acid, Peptide, or Protein
- Pharmacologic Substance
- Immunologic Factor